HM Payson & Co’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $101K | Sell |
6,330
-74
| -1% | -$1.15K | ﹤0.01% | 568 |
|
|
2026
Q1 | $86.5K | Buy |
6,404
+333
| +5% | +$4.66K | ﹤0.01% | 586 |
|
|
2025
Q4 | $75.6K | Sell |
6,071
-20
| -0.3% | -$216 | ﹤0.01% | 618 |
|
|
2025
Q3 | $60.3K | Buy |
6,091
+56
| +0.9% | +$545 | ﹤0.01% | 649 |
|
|
2025
Q2 | $53.9K | Sell |
6,035
-482
| -7% | -$4.08K | ﹤0.01% | 636 |
|
|
2025
Q1 | $56.8K | Buy |
6,517
+45
| +0.7% | +$472 | ﹤0.01% | 628 |
|
|
2024
Q4 | $80.6K | Sell |
6,472
-101
| -2% | -$1.24K | ﹤0.01% | 567 |
|
|
2024
Q3 | $76.3K | Buy |
6,573
+33
| +0.5% | +$381 | ﹤0.01% | 567 |
|
|
2024
Q2 | $69.5K | Sell |
6,540
-256
| -4% | -$2.83K | ﹤0.01% | 548 |
|
|
2024
Q1 | $81.1K | Sell |
6,796
-730
| -10% | -$8.79K | ﹤0.01% | 527 |
|
|
2023
Q4 | $81.5K | Sell |
7,526
-8,374
| -53% | -$80.2K | ﹤0.01% | 518 |
|
|
2023
Q3 | $157K | Sell |
15,900
-49
| -0.3% | -$510 | ﹤0.01% | 416 |
|
|
2023
Q2 | $159K | Sell |
15,949
-1,705
| -10% | -$16.3K | ﹤0.01% | 406 |
|
|
2023
Q1 | $170K | Sell |
17,654
-2,084
| -11% | -$23.1K | ﹤0.01% | 396 |
|
|
2022
Q4 | $220K | Sell |
19,738
-1,720
| -8% | -$18K | 0.01% | 352 |
|
|
2022
Q3 | $183K | Sell |
21,458
-439
| -2% | -$4.32K | 0.01% | 384 |
|
|
2022
Q2 | $229K | Sell |
21,897
-955
| -4% | -$10.5K | 0.01% | 353 |
|
|
2022
Q1 | $249K | Sell |
22,852
-7,893
| -26% | -$104K | 0.01% | 365 |
|
|
2021
Q4 | $416K | Sell |
30,745
-4,008
| -12% | -$53.5K | 0.01% | 304 |
|
|
2021
Q3 | $471K | Sell |
34,753
-6,451
| -16% | -$91.5K | 0.01% | 282 |
|
|
2021
Q2 | $589K | Sell |
41,204
-15,845
| -28% | -$229K | 0.01% | 255 |
|
|
2021
Q1 | $797K | Sell |
57,049
-126,391
| -69% | -$2.06M | 0.02% | 225 |
|
|
2020
Q4 | $3.44M | Buy |
+183,440
| New | +$2.99M | 0.1% | 121 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$3K | – | 940 |
|
|
2020
Q1 | $3K | Sell |
200
-60
| -23% | -$1.15K | ﹤0.01% | 850 |
|
|
2019
Q4 | $5K | Sell |
260
-600
| -70% | -$11.2K | ﹤0.01% | 866 |
|
|
2019
Q3 | $17K | Hold |
860
| – | – | ﹤0.01% | 754 |
|
|
2019
Q2 | $16K | Buy |
+860
| New | +$19K | ﹤0.01% | 757 |
|
|
2018
Q3 | – | Sell |
-14,090
| Closed | -$509K | – | 363 |
|
|
2018
Q2 | $509K | Buy |
+14,090
| New | +$553K | 0.02% | 224 |
|
|
2018
Q1 | – | Sell |
-21,938
| Closed | -$928K | – | 357 |
|
|
2017
Q4 | $928K | Buy |
21,938
+1,498
| +7% | +$57.3K | 0.04% | 196 |
|
|
2017
Q3 | $641K | Sell |
20,440
-182,524
| -90% | -$6.2M | 0.03% | 216 |
|
|
2017
Q2 | $7.88M | Buy |
+202,964
| New | +$7.79M | 0.36% | 69 |
|
|
2017
Q1 | – | Sell |
-202,193
| Closed | -$7.71M | – | 351 |
|
|
2016
Q4 | $7.71M | Sell |
202,193
-15,398
| -7% | -$572K | 0.37% | 72 |
|
|
2016
Q3 | $8.29M | Buy |
217,591
+34,089
| +19% | +$1.52M | 0.4% | 65 |
|
|
2016
Q2 | $7.93M | Buy |
+183,502
| New | +$8.12M | 0.4% | 65 |
|
|
2016
Q1 | – | Sell |
-174,494
| Closed | -$9.44M | – | 349 |
|
|
2015
Q4 | $9.44M | Buy |
+174,494
| New | +$8.39M | 0.49% | 58 |
|
|
2015
Q3 | – | Sell |
-142,723
| Closed | -$9.69M | – | 310 |
|
|
2015
Q2 | $9.69M | Buy |
+142,723
| New | +$10.1M | 0.48% | 61 |
|
Other funds holding VTRS
ACM
WCM
TIM
QAM
PCM
SIS
ETC
HM Payson & Co's VTRS Position: Q2 2026 in Review
HM Payson & Co reduced its Viatris (VTRS) stake by 1.2% in Q2 2026, selling an estimated $1.15K and leaving 6,330 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #568.
HM Payson & Co first reported a position in VTRS in Q2 2015 and has held it in 36 quarters since. The position peaked at $9.69M in Q2 2015. 268 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- HM Payson & Co held 6,330 shares of Viatris worth $101K as of Q2 2026.
- HM Payson & Co sold 74 Viatris shares in Q2 2026, an estimated $1.15K.
- Viatris made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #568 holding.
- HM Payson & Co first reported a position in Viatris in Q2 2015 and has held it in 36 quarters since.
- HM Payson & Co's Viatris position peaked at $9.69M in Q2 2015.
- 268 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.